In Brief - Veeva Systems (VEEV) Stock

Shares of Healthcare sector company Veeva Systems moved 5.3% today, and are now trading at a price of $166.82. The large-cap stock's daily volume was 3,173,076 compared to its average volume of 1,016,495. The S&P 500 index returned a -0.4% performance.

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company is based in Pleasanton and has 5,482 full time employees. Its market capitalization is $25,904,750,592.

24 analysts are following Veeva Systems and have set target prices ranging from $180 to $250 per share. On average, they have given the company a rating of buy. At today's prices, VEEV is trading -21.88% away from its average analyst target price of $213.54 per share.

Over the last year, VEEV shares have gone down by -50.5%, which represents a difference of -30.8% when compared to the S&P 500. The stock's 52 week high is $323.46 per share and its 52 week low is $151.02. With average free cash flows of $506,718,500.0 that have been growing at an average rate of 35.8% over the last four years, Veeva Systems declining stock performance may not be reflective of the quality of its underlying business.

For a deeper fundamental analysis into Veeva Systems and other market moving stocks, subscribe to our free newsletter today!

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS